Patient factor | Viral loadv | P-value | ||
---|---|---|---|---|
Low N = 22 (%) | Moderate N = 38 (%) | High N = 28 (%) | ||
Male gendera | 15 (68) | 25 (66) | 16 (57) | 0.5c |
Ageb | 59 ± 15 | 59 ± 13 | 60 ± 15 | 0.9d |
Critical diseasea | 4 (18) | 11 (29) | 5 (18) | 0.1c |
Severe diseasea | 7 (32) | 12 (32) | 5 (18) | 0.2c |
Days spent in hospitalb | 14 ± 15 | 17 ± 18 | 17 ± 22 | 0.9d |
Days of symptoms prior to stool samplingb | 14 ± 5 | 12 ± 4 | 11 ± 4 | 0.09d |
Thirty-day mortalitya | 1 (5) | 2 (5) | 0 (0) | 0.7c |
CRP maximum (mg/L)b | 160 ± 70 | 160 ± 80 | 130 ± 90 | 0.4d |
Lymphocytes minimum (109/L)b | 0.8 ± 0.3 | 0.9 ± 0.4 | 0.9 ± 0.3 | 0.7d |
Body mass index (kg/m2)b | 30 ± 5 | 30 ± 7 | 29 ± 5 | 0.9d |
Hypertensiona | 7 (32) | 15 (39) | 10 (36) | 0.6c |
Other morbidityaf | 9 (41) | 7 (18) | 13 (46) | 0.07c |
Immunosuppressiona | 1 (5) | 1 (3) | 2 (7) | 0.8c |
Remdesivir treatmenta | 1 (5) | 2 (5) | 2 (7) | 1c |
Corticosteroid treatmenta | 17 (77) | 34 (89) | 19 (68) | 0.2c |
IL6 receptor-inhibitor treatmenta | 3 (14) | 2 (5) | 2 (7) | 0.7c |